Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease

NCT02730793 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped terminated due to an inability to recruit study subjects

Conditions

Cystic Fibrosis

Interventions

DRUG: Oral Aztreonam
DRUG: Nasal Aztreonam
DRUG: Nasal Placebo

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]